3型巴特综合征的临床与遗传谱
该研究对115例CLCNKB突变患者进行基因分析并回顾病历,发现29.5%为产前/新生儿型、44.5%为经典型、26.0%为Gitelman样;中位随访8年后25%出现慢性肾功能衰竭,功能完全丧失突变与更早诊断相关。
要点
- 3型巴特综合征表型异质,可分为产前/新生儿型、经典型和Gitelman样。
- 严重突变或残余氯电导低的错义突变与诊断年龄更小相关。
- 所有表型均可发生慢性肾脏病,中位随访8年时25%出现慢性肾功能衰竭。
核心结论
- 3型巴特综合征存在基因型/表型关联:功能完全丧失突变与更早诊断年龄相关,且慢性肾脏病可见于所有表型。
研究设计与样本
- 回顾性分析115例CLCNKB突变患者的病历,通过直接测序和多重连接依赖探针扩增进行基因分析。
- 对8个错义突变和2个无义突变在非洲爪蟾卵母细胞中进行功能分析。
主要发现
- 共检测到60个突变,其中27个为既往未报道的突变。
- 29.5%患者为产前/新生儿型巴特综合征,44.5%为经典型巴特综合征,26.0%为Gitelman样综合征。
- 体外表达的10个突变中9个降低或消除氯电导。
- 77例患者中位随访8年(范围1-41年),19例(25%)检测到慢性肾功能衰竭,其中1例需血液透析、4例接受肾移植。
关键数值与推荐
- 严重突变(大缺失、移码、无义和 essential splicing)及导致残余电导低的错义突变与诊断年龄更小相关。
- 电解质补充剂和吲哚美辛常用于促进追赶生长,不良反应少。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (CLCNKB), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule. To study phenotype/genotype correlations, we performed genetic analyses by direct sequencing and multiplex ligation-dependent probe amplification and retrospectively analyzed medical charts for 115 patients with CLCNKB mutations. Functional analyses were performed in Xenopus laevis oocytes for eight missense and two nonsense mutations. We detected 60 mutations, including 27 previously unreported mutations. Among patients, 29.5% had a phenotype of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood). Nine of the ten mutations expressed in vitro decreased or abolished chloride conductance. Severe (large deletions, frameshift, nonsense, and essential splicing) and missense mutations resulting in poor residual conductance were associated with younger age at diagnosis. Electrolyte supplements and indomethacin were used frequently to induce catch-up growth, with few adverse effects. After a median follow-up of 8 (range, 1-41) years in 77 patients, chronic renal failure was detected in 19 patients (25%): one required hemodialysis and four underwent renal transplant. In summary, we report a genotype/phenotype correlation for Bartter syndrome type 3: complete loss-of-function mutations associated with younger age at diagnosis, and CKD was observed in all phenotypes.
引用
- Seys E, Andrini O, Keck M, et al. Clinical and Genetic Spectrum of Bartter Syndrome Type 3. J Am Soc Nephrol. 2017. PMID: 28381550. doi:10.1681/ASN.2016101057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。